FourThought Financial, LLC - REVANCE THERAPEUTICS INC ownership

REVANCE THERAPEUTICS INC's ticker is RVNC and the CUSIP is 761330109. A total of 152 filers reported holding REVANCE THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 2.06 and the average weighting 0.2%.

Quarter-by-quarter ownership
FourThought Financial, LLC ownership history of REVANCE THERAPEUTICS INC
ValueSharesWeighting
Q3 2022$66,000
+94.1%
2,4530.0%0.01%
+100.0%
Q2 2022$34,000
-15.0%
2,453
+20.8%
0.01%0.0%
Q1 2022$40,000
+37.9%
2,031
+15.3%
0.01%
+25.0%
Q4 2021$29,000
-48.2%
1,762
-13.5%
0.00%
-42.9%
Q3 2021$56,000
-5.1%
2,036
+0.8%
0.01%
-12.5%
Q2 2021$59,000
+9.3%
2,019
+4.1%
0.01%0.0%
Q1 2021$54,000
-14.3%
1,940
-12.8%
0.01%
-20.0%
Q4 2020$63,0002,2240.01%
Other shareholders
REVANCE THERAPEUTICS INC shareholders Q4 2020
NameSharesValueWeighting ↓
Palo Alto Investors LP 4,405,039$118,936,0009.40%
Essex Woodlands Management, Inc. 457,085$12,341,0005.10%
Evolutionary Tree Capital Management, LLC 191,868$5,180,0004.98%
Ghost Tree Capital, LLC 390,000$10,530,0002.96%
Antara Capital LP 4,069,400$109,874,0002.90%
RICE HALL JAMES & ASSOCIATES, LLC 896,754$24,212,0001.40%
Jericho Capital Asset Management L.P. 714,000$19,278,0001.22%
Antara Capital LP 1,600,000$43,200,0001.14%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 120,000$3,240,0001.04%
TANG CAPITAL MANAGEMENT LLC 287,500$7,763,0000.95%
View complete list of REVANCE THERAPEUTICS INC shareholders